Furthermore, BChE has found to be upregulated in schizophrenia patients, and when treated with rivastigmine, an inhibitor of BChE and acetylcholinesterase, their quality of life was improved (Lenzi et al., 2003). This evidence concerns the gene ACHE and schizophrenia.